This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 26, 2012

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

As 2012 comes to a close, ASCT would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of ASCT Viewpoint a look at the most accessed articles from the year. Our regular publication will resume Wednesday, Jan. 9, 2013.


New test may improve cervical cancer detection
University of Gothenburg via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From Nov. 28: Routine smear tests have considerably reduced the number of cases of cervical cancer, but despite intensive screening 250 women in Sweden still die from the disease every year. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have developed new methods of minimizing the number of missed cases and making diagnosis more reliable. More



Researchers find origin cells for cervical cancer
AFP via Google    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From June 27: Researchers have found the cells at the origin of cervical cancer, in a discovery that could offer new ways to prevent and treat the disease, according to a U.S.-published study. Most cases of cervical cancer are known to be caused by specific strains of human papillomavirus, but now researchers know the specific group of cells that HPV targets, said the study in the Proceedings of the National Academy of Sciences. More

Scientists solve key piece of prostate cancer puzzle
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer Research U.K. scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease. Prostate cancers are often treated with hormone therapies that target the androgen receptor — a large protein that switches on signals telling the cell to divide, and which can become overactive in prostate cancer cells. More

Study finds HPV vaccine Gardasil safe
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study of Merck Co.'s Gardasil cervical-cancer vaccine showed it was associated with fainting on the day of inoculation and skin infections two weeks afterward, but no link with more serious health problems was found. The vaccine protects against four strains of the human papillomavirus, or HPV, two of which account for about 70 percent of cervical-cancer cases in women. More

Smoking tied to 1 type of skin cancer
Reuters via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Smoking may not only cause wrinkles and sagging skin, it might also increase risk of one type of skin cancer, researchers suggest. Studies have linked smoking to a long list of health effects, including heart disease and lung cancer, but the evidence has been mixed for skin cancer. More

Pelvic exams: New guidelines for asymptomatic women
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American College of Obstetricians and Gynecologists has issued updated guidelines for annual "Well Woman" assessments with specific recommendations on when to perform pelvic exams in asymptomatic women and when to begin clinical breast exams. The opinion supplements ACOG's physical exam recommendations, which were updated in 2011 and recommend exam requirements including schedules for vaccinations and screening such as Papanicolaou smears and bone mineral density tests. More

Should young men be vaccinated against human papillomavirus?
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study published in Viral Immunology has sparked a debate on whether the human papillomavirus vaccination should be given to men. The review — available at www.liebertpub.com — was conducted by Gorren Low and colleagues from the University of Southern California and David Geffen School of Medicine, Los Angeles, and Georgetown University School of Medicine, Washington, D.C. The researchers assessed how cost effective it is to expand routine HPV vaccination to include young males as well as the potential for reducing illness caused by HPV infection. More

Researchers connect 2 viruses to prostate cancer
Private MD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From Aug. 8: A team of scientists found possible links between prostate cancer and both the human papillomavirus and Epstein Barr virus. These results may have implications for men who, with the help of a lab test, discover that they have this malignant disease. Both HPV and EBV have been associated with cancer. In order to elucidate any possible relationships with prostate malignancies, researchers from the University of New South Wales in Australia studied 100 prostate samples that were collected from men who had malignant or benign disease, as well as healthy males. More

RLIP76 contributes to pancreatic cancer cell resistance to chemotherapy, radiation
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From June 27: Researchers at the City of Hope Comprehensive Cancer Center in Duarte, Calif., have not only identified a protein that allows pancreatic cancer cells to resist therapy but also developed a way to block it, according to results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference. More

Tending the body's microbial garden
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
From June 27: For a century, doctors have waged war against bacteria, using antibiotics as their weapons. But that relationship is changing as scientists become more familiar with the 100 trillion microbes that call us home — collectively known as the microbiome. "I would like to lose the language of warfare," said Julie Segre, a senior investigator at the National Human Genome Research Institute. "It does a disservice to all the bacteria that have co-evolved with us and are maintaining the health of our bodies." This new approach to health is known as medical ecology. More


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec 2, 2013
Dec. 12, 2012
Nov. 28, 2012
Nov. 14, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063